Total Valuation
Lobe Sciences has a market cap or net worth of €15.89M. The enterprise value is €13.06.
Market Cap€15.89M
Enterprise Value€13.06
Share Statistics
Lobe Sciences has 284,102,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding284,102,500
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Lobe Sciences’s return on equity (ROE) is -1.88 and return on invested capital (ROIC) is -80.88%.
Return on Equity (ROE)-1.88
Return on Assets (ROA)-0.58
Return on Invested Capital (ROIC)-80.88%
Return on Capital Employed (ROCE)-0.81
Revenue Per Employee0.00
Profits Per Employee-885.53K
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Lobe Sciences is ―. Lobe Sciences’s PEG ratio is 0.13.
PE Ratio―
PS Ratio0.00
PB Ratio2.94
Price to Fair Value2.94
Price to FCF-4.89
Price to Operating Cash Flow-7.04
PEG Ratio0.13
Income Statement
In the last 12 months, Lobe Sciences had revenue of 0.00 and earned -4.43M in profits. Earnings per share was -0.03.
Revenue0.00
Gross Profit0.00
Operating Income-4.18M
Pretax Income-4.86M
Net Income-4.43M
EBITDA-4.27M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -3.44M and capital expenditures -8.00, giving a free cash flow of -3.44M billion.
Operating Cash Flow-3.44M
Free Cash Flow-3.44M
Free Cash Flow per Share-0.01
Dividends & Yields
Lobe Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.29
52-Week Price Change78.57%
50-Day Moving Average0.02
200-Day Moving Average―
Relative Strength Index (RSI)58.94
Average Volume (3m)0.00
Important Dates
Lobe Sciences upcoming earnings date is Dec 18, 2026, TBA (Confirmed).
Last Earnings DateJul 30, 2026
Next Earnings DateDec 18, 2026
Ex-Dividend Date―
Financial Position
Lobe Sciences as a current ratio of 3.13, with Debt / Equity ratio of 103.95%
Current Ratio3.13
Quick Ratio3.13
Debt to Market Cap0.04
Net Debt to EBITDA1.31
Interest Coverage Ratio-7.00
Taxes
In the past 12 months, Lobe Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Lobe Sciences EV to EBITDA ratio is -0.32, with an EV/FCF ratio of -0.96.
EV to Sales0.00
EV to EBITDA-0.32
EV to Free Cash Flow-0.96
EV to Operating Cash Flow-0.96
Balance Sheet
Lobe Sciences has €4.96M in cash and marketable securities with €316.49K in debt, giving a net cash position of €4.64M billion.
Cash & Marketable Securities€4.96M
Total Debt€316.49K
Net Cash€4.64M
Net Cash Per Share€0.02
Tangible Book Value Per Share€0.04
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Lobe Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast18.92%